HIGHLIGHTS
- who: Cristina Dalmiglio and colleagues from the Unit of Endocrinology, Department of Medical, Surgical and Neurological, University of Siena, Siena, Italy have published the article: Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors, in the Journal: Cancers 2022, 14, 4569. of /2022/
- what: Sarcopenia may be a useful outcome predictor for advanced thyroid cancer patients undergoing TKI treatment.
- how: The results are comparable to those reported in an Asian population with advanced thyroid cancer in which the presence of pre-treatment sarcopenia measured . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.